Jason Phowira
Dr Sherin Bakhashab
Anuradha Doddaballapur
Dr Jolanta Weaver
| Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function | 2022 |
|
Jason Phowira
Dr Fahad Ahmed
Dr Sherin Bakhashab
Dr Jolanta Weaver
| Upregulated miR-18a-5p in Colony Forming Unit-Hill’s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study | 2022 |
|
Dr Sherin Bakhashab
Jevi Latief
Dr Jolanta Weaver
| MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus) | 2021 |
|
Sabby Ray
Alice Tamara
Jevi Latief
Dr Sherin Bakhashab
Dr Jolanta Weaver
et al. | The role of miR-342 in vascular health. Study in subclinical cardiovascular disease in mononuclear cells, plasma, inflammatory cytokines and PANX2 | 2020 |
|
Dr Fahad Ahmed
Dr Sherin Bakhashab
INDA Bastaman
Dr Rachel Crossland
Dr Michael Glanville
et al. | Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study | 2018 |
|
Dr Sherin Bakhashab
Dr Fahad Ahmed
Dr Michael Glanville
Dr Jolanta Weaver
| Proangiogenic effect of metformin in endothelial cells is via upregulation of VEGFR1/2 and their signaling under hyperglycemia-hypoxia | 2018 |
|
Dr Sherin Bakhashab
Dr Jolanta Weaver
| Microarray expression profiling identifies genes, including cytokines, and biofunctions, as diapedesis, associated with a brain metastasis from a papillary thyroid carcinoma | 2016 |
|
